Lazar David E. → NovaBay Pharmaceuticals, Inc. SDEV

Stake: 4.99% Shares: 6,388,000 CUSIP: 66987P409 Class: Common Stock, $0.01 par value

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on NovaBay Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2026-01-21	SCHEDULE	Framework Ventures IV L.P.	45.00%	56,806,080	view →
2026-01-21	SCHEDULE	R01 Fund LP	45.00%	56,806,080	view →

Other Filings by Lazar David E.

Filed	Form	Issuer	Stake	Shares
2026-04-28	SCHEDULE 13D	MAINZ BIOMED N.V. QUCY	97.40%	477,000,000	view →
2025-03-10	SCHEDULE	FiEE, Inc. FIEE	35.10%	2,802,254	view →
2022-07-11	SC	EQUUS TOTAL RETURN, INC. EQS	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →